Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft

Liver Transplantation

Volumn 15, Issue 5, 2009, Pages 496-503

  Yi, Nam Joon ^a   Suh, Kyung Suk ^a   Lee, Hae Won ^a   Shin, Woo Young ^a   Kim, Juhyun ^a   Kim, Won ^a   Kim, Yoon Jun ^a   Yoon, Jung Hwan ^a   Lee, Hyo Suk ^a   Lee, Kuhn Uk ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CLINICAL ASSESSMENT TOOL; COLD ISCHEMIA; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT REJECTION; HEMOPERITONEUM; HEPATIC ARTERY STENOSIS; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; ILEUS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MELD SCORE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORBIDITY; NEPHROTOXICITY; NEUROTOXICITY; OPERATION DURATION; ORGAN SIZE; OUTCOME ASSESSMENT; PATIENT SELECTION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM; SMALL FOR SIZE GRAFT; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; ADOLESCENT; GRAFT SURVIVAL; HOSPITALIZATION; KAPLAN MEIER METHOD; KOREA; LIVER; LIVER TUMOR; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; ORGAN SIZE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649975639     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21606     Document Type: Article

References (40)

1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, terBorg PC. A model for predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
2. Kamath PS, Weisner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-470.
3. Weisner RH, McDiarmid SV, Kamath PS, Edward EB. Malinchoc M, Kremers WK, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
4. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, et al. Prediction outcome after liver transplantation: Utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
5. United Network for Organ Sharing (UNOS). http://www.unos.org. Assessed January 1, 2006.
6. Santori G, Andorno E, Mrelli N, Antonucci A, Boiino G, Modello R, et al. MELD score versus conventional UNOS status in predicting short-term mortality after liver transplantation. Transpl Int 2005;18:65-72.
7. Brown Jr. RS, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in united network for organ sharing status 2A patients. Liver Transpl 2002;8:278-284.
8. Onaca NN, Nevy MF, Nett GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transpl 2003;3:626-630.
9. Onaca NN, Nevy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplant MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
10. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003; 9:473-476.
11. Jacob M, Copley LP, Lewsey JD, Gimson A, Toogood GJ, Rela M, et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004;10:903-907.
12. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999:67:321-327.
13. Kiuchi T, Tanaka K, Ito T, Oike F, Ogura Y, Fujimoto Y, et al. Small-for-size graft in living donor liver transplantation: how far should we go ? Liver Transpl 2003;9:S29-S35.
14. Sugawars Y, Makuuchi M. Small-for-size graft problems in adult-to-adult living-donor liver transplantation. Transplantation 2003;73(3):S20-S22.
15. Lo C, Liu C, Fan ST. Portal hyperperfusion injury as the cause of primary nonfunction in a small-for-size liver graft - successful treatment with splenic artery ligation. Liver Transpl 2003;9:626-628.
16. Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004;10:1263-1268.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
18. Clavien PA, Camargo CA Jr, Croxford R, Langer B, Levy GA, Greig PD. Definition and classification of negative outcomes in solid organ transplantation. Application in liver transplantation. Ann Surg 1994:220:109-120.
19. Ghobrial RM, Saab S, Lassman C, Lu D, Raman S, Limanond P, et al. Donor and recipient outcomes in right lobe adult living donor liver transplantation. Liver Transpl 2002;8:901-909.
20. Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, et al. Hypoattenuation in unenhanced CT reflects hitological graft dysfunction and predicts 1-year mortality after living donor liver transplantation. Liver Transpl 2006;12:1403-1411.
21. Yi NJ, Suh KS, Cho JY, Lee HW, Cho EH, Yang SH, et al. Three-quarters of right liver donors experienced postoperative complications. Liver Transpl 2007;13:797-806.
22. Suh KS, Yi NJ, Cho JY, Kwon CH, Minn KW, Lee KU. Technical refinement preserving segment 4 to donor in extended right hepatectomy. Hepatogastroenterology 2006; 53:253-7.
23. Cho EH, Suh KS, Lee HW, Shin WY, Yi NJ, Lee KU. Safety of modified extended right hepatectomy in living liver donors. Transpl Int 2007;9:779-783.
24. Suh KS. Technical variations in living donor liver transplantation. Curr Opin Orang Transpl 2004;9:90-98.
25. Yi NJ, Suh KS, Lee HW, Cho EH, Shin WY, Cho JY, Lee KU. An artificial vascular graft is a useful interpositional material for drainage of the right anterior section in living donor liver transplantation. Liver Transpl 2007;13:1159-1167.
26. Xia VW, Du B, Braunfeld M. Neelakanta G, Hu KQ, Nourmand H, et al. Preoperative characteristics and Intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl 2006; 12:614-620.
27. Habib S, Berk B, Chang CH, Demetris AJ, Fontes P, Dvorchik I, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006;12:440-447.
28. Hayashi PH, Foreman L, Steinberg T, Bak T, Wachs M, Kugelmas M, et al. Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplantation recipients. Liver Transpl 2003;9:737-740.
29. Terrault NA, Shiffamn ML, Lok ASF, Saab S, Tong L, Brwon Jr. RS, et al. Outcome in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl 2007;13:122-129.
30. Uchida Y, Kasahara M, Egawa H, takada Y, ogawa K, Ogura Y, et al. Long-term outcome of adult-to-adult living donor liver transplantation for post-Kasai biliary atresia. Am J Transpl 2006;6:2443-2448.
31. Yi NJ, Suh KS, Cho YB, Lee HW, Shin WY, Kim J, et al. The right small-for-size graft results in less arduous small-for-size graft syndrome than the left one in adult-to-adult living donor liver transplantation. World J Surg 2008;14: Epub ahead of print.
32. Chan SC, Fan ST, Lo CM, Liu CL. Effect of side and size of graft on surgical outcome of adult-to-adult live donor liver transplantation. Liver Transpl 2007;13:91-98.
33. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, et al. Outcome of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005;242:314-325.
34. Broering DC, Kim JS, Mueller T, Fischer L, Ganschow R, Bicak T, et al. One hundred thirty-two consecutive pediatric liver transplants without hospital mortality. Ann Surg 2004;240:1002-1012.
35. Busuttil RW, Farmer DG, Yersiz H, Hiatt JR, McDiarmid SV, Goldsteoin LI, et al. Analysis of long-term outcomes of 3200 liver transplantation over two decades: a single-center experience. Ann Surg 2005;241:905-916.
36. Suh KS, Kim SH, Kim SB, Lee HJ, Lee KU. Safety of right lobectomy in living donor liver transplantation. Liver Transpl 2002;8:910-915.
37. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36.
38. Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, et al. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma. Surgery 2007;141:598-609.
39. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P. Venook A, et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
40. Yang SH, Suh KS, Lee HW, Cho EH, Cho JY, Cho YB, et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 2006;12;1655-1660.